Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Vasir JK, Labhasetwar V.

Adv Drug Deliv Rev. 2007 Aug 10;59(8):718-28. Epub 2007 Jun 26. Review.

2.

Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.

Duan Y, Sun X, Gong T, Wang Q, Zhang Z.

J Mater Sci Mater Med. 2006 Jun;17(6):509-16.

PMID:
16691348
3.

Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.

Wang G, Yu B, Wu Y, Huang B, Yuan Y, Liu CS.

Int J Pharm. 2013 Mar 25;446(1-2):24-33. doi: 10.1016/j.ijpharm.2013.02.004. Epub 2013 Feb 10.

PMID:
23402977
4.

Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.

Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, Ji W, Wu B, Han J, Zhang H, Wang H, Chang J, Niu R.

Eur J Pharm Biopharm. 2012 Jun;81(2):248-56. doi: 10.1016/j.ejpb.2012.03.004. Epub 2012 Mar 14.

PMID:
22446630
5.

Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Sah H, Thoma LA, Desu HR, Sah E, Wood GC.

Int J Nanomedicine. 2013;8:747-65. doi: 10.2147/IJN.S40579. Epub 2013 Feb 21. Review.

6.

Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.

Schwach G, Oudry N, Delhomme S, Lück M, Lindner H, Gurny R.

Eur J Pharm Biopharm. 2003 Nov;56(3):327-36.

PMID:
14602174
7.

Protein instability in poly(lactic-co-glycolic acid) microparticles.

van de Weert M, Hennink WE, Jiskoot W.

Pharm Res. 2000 Oct;17(10):1159-67. Review.

PMID:
11145219
8.

PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.).

Fredriksen BN, Grip J.

Vaccine. 2012 Jan 11;30(3):656-67. doi: 10.1016/j.vaccine.2011.10.105. Epub 2011 Nov 18.

PMID:
22100638
9.

Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.

Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN.

J Control Release. 2007 May 14;119(1):77-85. Epub 2007 Feb 3.

PMID:
17349712
10.

Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.

Yoo HS, Oh JE, Lee KH, Park TG.

Pharm Res. 1999 Jul;16(7):1114-8.

PMID:
10450940
11.

Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

Panyam J, Labhasetwar V.

Adv Drug Deliv Rev. 2003 Feb 24;55(3):329-47. Review.

PMID:
12628320
12.

Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.

Joung YK, Son S, Jang JY, Kwon MH, Park KD.

Pharm Res. 2012 Apr;29(4):932-42. doi: 10.1007/s11095-011-0633-0. Epub 2011 Dec 3.

PMID:
22139535
13.

Encapsulation of beraprost sodium in nanoparticles: analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension.

Ishihara T, Hayashi E, Yamamoto S, Kobayashi C, Tamura Y, Sawazaki R, Tamura F, Tahara K, Kasahara T, Ishihara T, Takenaga M, Fukuda K, Mizushima T.

J Control Release. 2015 Jan 10;197:97-104. doi: 10.1016/j.jconrel.2014.10.029. Epub 2014 Nov 6.

PMID:
25449809
14.

Design of biodegradable particles for protein delivery.

Vila A, Sánchez A, Tobío M, Calvo P, Alonso MJ.

J Control Release. 2002 Jan 17;78(1-3):15-24.

PMID:
11772445
15.

Efficient encapsulation of a water-soluble corticosteroid in biodegradable nanoparticles.

Ishihara T, Takahashi M, Higaki M, Mizushima Y.

Int J Pharm. 2009 Jan 5;365(1-2):200-5. doi: 10.1016/j.ijpharm.2008.08.030. Epub 2008 Aug 29.

PMID:
18804157
16.
17.

Novel multi-biotin grafted poly(lactic acid) and its self-assembling nanoparticles capable of binding to streptavidin.

Yan H, Jiang W, Zhang Y, Liu Y, Wang B, Yang L, Deng L, Singh GK, Pan J.

Int J Nanomedicine. 2012;7:457-65. doi: 10.2147/IJN.S24011. Epub 2012 Jan 31.

18.

Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.

Vandorpe J, Schacht E, Dunn S, Hawley A, Stolnik S, Davis SS, Garnett MC, Davies MC, Illum L.

Biomaterials. 1997 Sep;18(17):1147-52.

PMID:
9259511
19.

[Current status and perspective of research on PEG-PLGA].

Zhou HN, Li YM, Liu T.

Zhonghua Zhong Liu Za Zhi. 2010 Aug;32(8):561-3. Review. Chinese. No abstract available.

PMID:
21122404
20.

Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.

Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.

Nanomedicine. 2007 Dec;3(4):246-57.

PMID:
18068091

Supplemental Content

Support Center